explore -WSS

explore

author：explore 2025-09-30 04:54:39 - browse：15

Cathy McMorris Rodgers -- health policy coverage from STAT — Rep. Cathy McMorris Rodgers (R-Wash.), chair of the House Energy and Commerce Committee. Anna Moneymaker/Getty Images

WASHINGTON — House Republicans have drafted drug-shortage legislation that differs significantly from the approach Democrats propose to stem shortages of chemotherapies and other critical medicines that hospitals typically use.

Republicans on the House Energy and Commerce Committee are focused on what they say are the underlying economic reasons for shortages. Hospitals band together to negotiate drug prices, and makers of generic injectables say those group purchasing organizations can drive prices down so low that they stop making certain drugs or can’t afford to maintain manufacturing facilities, which then leads to manufacturing interruptions.

Rep. Frank Pallone (D-N.J.), the ranking Democrat on Energy and Commerce, called some of the Republican proposals “handouts” to drug companies and said they don’t fix the problem. Democrats also have been critical of Republicans’ choice to separate the drug shortage policies from a must-pass pandemic-preparedness bill — they’d rather combine the two efforts to increase its chances of success.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Steward Health Care expansion into Malta flopped

WSS

Hospital chaplains balance Covid safety with patients’ spiritual needs

Pfizer, Moderna say biotech, pharma drug development is a sprint

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

Readout LOUD podcast, live from the STAT Breakthrough Summit East

Pregnancy ages women, but effects reverse after delivery

Medicare Advantage coverage denials need scrutiny, senators say

hotspot

explore

focus

Peter Hotez and the public health issue of online harassment

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

Moonlake's readout produced a cash windfall. Risks remain

Medicare Advantage insurers pressure Biden for bigger payments

Duchenne breakthrough therapy leaves behind pioneering families

Biotech investment managers search for lucrative opportunities

Affirmative action in medical school literally saved lives

Medicare Advantage overpayments discussion gets experts fired up

Moonlake's readout produced a cash windfall. Risks remain

Mirador, a new biotech startup, launches with $400 million

knowledge

Profiling embryos to choose those with higher IQs is almost a reality

American taxpayers paid $1.8 trillion in health care costs in 2022

Pfizer, Moderna say biotech, pharma drug development is a sprint

Adam's Take: Intra

Merck to acquire Harpoon Therapeutics for $680 million

What Kate Middleton's cancer revelation might teach the world

leisure time

knowledge

explore

explore